SCM
NXTC icon

Silverarc Capital Management’s NextCure NXTC Stock Holding History

Silverarc Capital Management’s Portfolio NXTC Stock Details NXTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-176,057
Closed -$1.88M – 88
2026
Q1 		$1.88M Hold
176,057
– – 0.19% 59
2025
Q4 		$2.5M Buy
+176,057
New +$1.82M 0.35% 56
2022
Q2 		– Sell
-16,349
Closed -$953 – 81
2022
Q1 		$953 Buy
16,349
+265
+2% +$16.6K 0.39% 53
2021
Q4 		$1.16M Sell
16,084
-44,025
-73% -$3.68M 0.47% 57
2021
Q3 		$4.86M Buy
60,109
+36,317
+153% +$3.18M 2.75% 10
2021
Q2 		$2.29K Buy
+23,792
New +$2.43M 1.02% 35
2021
Q1 		– Sell
-10,833
Closed -$1.42M – 99
2020
Q4 		$1.42M Buy
+10,833
New +$1.4M 0.82% 41

Other funds holding NXTC

Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
P
Pfizer New York $170M AUM 191.09% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
PAP
Persistent Asset Partners Hong Kong $335M AUM 275.57% 1-Year Est. Return

Silverarc Capital Management's NXTC Position: Q2 2026 in Review

Silverarc Capital Management sold out of NextCure (NXTC) in Q2 2026, closing a stake of 176,057 shares — an estimated $1.88M sold.

Silverarc Capital Management first reported a position in NXTC in Q4 2020 and held it in 7 quarters. The position peaked at $4.86M in Q3 2021. 17 funds tracked by Wall St. Rank hold NXTC as of Q2 2026.

  • Silverarc Capital Management reported no remaining NextCure position as of Q2 2026 after selling out during the quarter.
  • Silverarc Capital Management sold 176,057 NextCure shares in Q2 2026, an estimated $1.88M.
  • Silverarc Capital Management first reported a position in NextCure in Q4 2020 and held it in 7 quarters.
  • Silverarc Capital Management's NextCure position peaked at $4.86M in Q3 2021.
  • 17 funds tracked by Wall St. Rank held NextCure as of Q2 2026.

Based on Silverarc Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.